These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. [Birt-Hogg-Dubé syndrome: report of a case]. Xu J; Jin GL; Wang YY; Zhang Y Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):679-681. PubMed ID: 35785847 [TBL] [Abstract][Full Text] [Related]
85. Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants. Verma S; Goyal S; Kumari A; Singh A; Jamal S; Grover A PLoS One; 2018; 13(2):e0190942. PubMed ID: 29389942 [TBL] [Abstract][Full Text] [Related]
86. Birt-Hogg-Dubé syndrome: report of a new mutation. Rehman HU Can Respir J; 2012; 19(3):193-5. PubMed ID: 22679611 [TBL] [Abstract][Full Text] [Related]
87. A case of Birt-Hogg-Dubé syndrome presenting with a single pedunculated fibrofolliculoma and a novel FLCN gene mutation. César A; Baudrier T; Mota A; Azevedo F Actas Dermosifiliogr; 2016; 107(6):541-3. PubMed ID: 27083392 [No Abstract] [Full Text] [Related]
88. Multiple desmoplastic melanomas in Birt-Hogg-Dubé syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility. Cocciolone RA; Crotty KA; Andrews L; Haass NK; Moloney FJ Arch Dermatol; 2010 Nov; 146(11):1316-8. PubMed ID: 21079084 [No Abstract] [Full Text] [Related]
90. Mutations induce conformational changes in folliculin C-terminal domain: possible cause of loss of guanine exchange factor activity and Birt-Hogg-Dubé syndrome. Verma S; Tyagi C; Goyal S; Pandey B; Jamal S; Singh A; Grover A J Biomol Struct Dyn; 2017 May; 35(7):1568-1573. PubMed ID: 27484154 [No Abstract] [Full Text] [Related]
91. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100 [TBL] [Abstract][Full Text] [Related]